Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Integra LifeSciences Holdings Corporation IART

Full chart Compare
Set alert

Price alert · IART

All alert types
14.82 USD +1.19 (+8.73%)

At closeNov 4, 2026, 4:01 PM EST

14.82 0.00 0.00%

After hours · Nov 4, 4:01 PM ET

13.84 Day range 15.15
8.70 52-week range 20.49
YTD
+19.32%
1 year
+31.15%

Financial health

Altman Z-Score

1.34 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

7 / 9 Strong

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

B3 / 5 overall

  • DCF 5
  • Return on Equity 2
  • Return on Assets 3
  • Debt / Equity 1
  • P/E 1
  • P/B 4

Valuation

P/E -1.8×
FY 2016: 42.9×FY 2017: 57.7×FY 2018: 61.8×FY 2019: 98.8×FY 2020: 41.1×FY 2021: 33.5×FY 2022: 25.7×FY 2023: 50.1×FY 2024: -251×FY 2025: -1.8×
FY 2016 5y median 25.7× FY 2025
P/S 0.6×
FY 2016: 3.2×FY 2017: 3.2×FY 2018: 2.5×FY 2019: 3.3×FY 2020: 4.0×FY 2021: 3.7×FY 2022: 3.0×FY 2023: 2.2×FY 2024: 1.1×FY 2025: 0.6×
FY 2016 5y median 2.2× FY 2025
P/B 0.9×
FY 2016: 3.8×FY 2017: 3.9×FY 2018: 2.7×FY 2019: 3.5×FY 2020: 3.6×FY 2021: 3.4×FY 2022: 2.6×FY 2023: 2.1×FY 2024: 1.1×FY 2025: 0.9×
FY 2016 5y median 2.1× FY 2025
P/FCF -21.1×
FY 2016: 46.4×FY 2017: 52.8×FY 2018: 30.6×FY 2019: 51.5×FY 2020: 39.3×FY 2021: 21.5×FY 2022: 21.4×FY 2023: 46.6×FY 2024: 70.0×FY 2025: -21.1×
FY 2016 5y median 21.5× FY 2025
EV/EBITDA -8.5×
FY 2016: 16.3×FY 2017: 40.1×FY 2018: 21.0×FY 2019: 28.0×FY 2020: 25.2×FY 2021: 18.8×FY 2022: 15.3×FY 2023: 18.8×FY 2024: 18.0×FY 2025: -8.5×
FY 2016 5y median 18.0× FY 2025
EV/Sales 1.7×
FY 2016: 3.8×FY 2017: 4.6×FY 2018: 3.4×FY 2019: 4.1×FY 2020: 4.9×FY 2021: 4.4×FY 2022: 3.7×FY 2023: 3.1×FY 2024: 2.2×FY 2025: 1.7×
FY 2016 5y median 3.1× FY 2025
FCF Yield -4.7%
FY 2016: 2.2%FY 2017: 1.9%FY 2018: 3.3%FY 2019: 1.9%FY 2020: 2.5%FY 2021: 4.7%FY 2022: 4.7%FY 2023: 2.1%FY 2024: 1.4%FY 2025: -4.7%
FY 2016 5y median 2.1% FY 2025

Profitability

Gross Margin 51.7%
FY 2016: 64.8%FY 2017: 63.3%FY 2018: 61.2%FY 2019: 62.8%FY 2020: 62.0%FY 2021: 61.2%FY 2022: 62.3%FY 2023: 57.4%FY 2024: 54.8%FY 2025: 51.7%
FY 2016 5y median 57.4% FY 2025
Operating Margin 4.2%
FY 2016: 11.6%FY 2017: 3.8%FY 2018: 7.5%FY 2019: 6.2%FY 2020: 11.0%FY 2021: 12.8%FY 2022: 15.3%FY 2023: 7.2%FY 2024: 1.8%FY 2025: 4.2%
FY 2016 5y median 7.2% FY 2025
Net Margin -31.6%
FY 2016: 7.5%FY 2017: 5.4%FY 2018: 4.1%FY 2019: 3.3%FY 2020: 9.8%FY 2021: 11.0%FY 2022: 11.6%FY 2023: 4.4%FY 2024: -0.4%FY 2025: -31.6%
FY 2016 5y median 4.4% FY 2025
ROE -49.5%
FY 2016: 8.9%FY 2017: 6.7%FY 2018: 4.4%FY 2019: 3.5%FY 2020: 8.8%FY 2021: 10.0%FY 2022: 10.0%FY 2023: 4.3%FY 2024: -0.4%FY 2025: -49.5%
FY 2016 5y median 4.3% FY 2025
ROIC 1.9%
FY 2016: 5.6%FY 2017: 1.5%FY 2018: 3.9%FY 2019: 2.6%FY 2020: 4.5%FY 2021: 4.4%FY 2022: 5.5%FY 2023: 2.7%FY 2024: 0.3%FY 2025: 1.9%
FY 2016 5y median 2.7% FY 2025
ROA -14.3%
FY 2016: 4.1%FY 2017: 2.0%FY 2018: 2.0%FY 2019: 1.5%FY 2020: 3.7%FY 2021: 4.5%FY 2022: 4.6%FY 2023: 1.8%FY 2024: -0.2%FY 2025: -14.3%
FY 2016 5y median 1.8% FY 2025

Growth (YoY)

Revenue 1.5%
FY 2016: 12.4%FY 2017: 19.8%FY 2018: 23.9%FY 2019: 3.1%FY 2020: -9.6%FY 2021: 12.4%FY 2022: 1.0%FY 2023: -1.0%FY 2024: 4.5%FY 2025: 1.5%
FY 2016 FY 2025
Operating Income 140.5%
FY 2016: 44.9%FY 2017: -61.2%FY 2018: 147.7%FY 2019: -15.5%FY 2020: 61.4%FY 2021: 30.3%FY 2022: 21.1%FY 2023: -53.3%FY 2024: -74.5%FY 2025: 140.5%
FY 2016 FY 2025
EPS (diluted) -7361.2%
FY 2016: 2074.8%FY 2017: -12.8%FY 2018: -12.2%FY 2019: -19.4%FY 2020: 170.7%FY 2021: 26.1%FY 2022: 9.1%FY 2023: -61.1%FY 2024: -110.7%FY 2025: -7361.2%
FY 2016 FY 2025
Free Cash Flow -281.3%
FY 2016: 13.1%FY 2017: 2.8%FY 2018: 71.7%FY 2019: -20.5%FY 2020: 44.4%FY 2021: 88.9%FY 2022: -17.8%FY 2023: -66.4%FY 2024: -65.8%FY 2025: -281.3%
FY 2016 FY 2025

Financial Health

Current Ratio 2.5×
FY 2016: 4.0×FY 2017: 2.4×FY 2018: 3.0×FY 2019: 2.6×FY 2020: 3.1×FY 2021: 3.4×FY 2022: 3.6×FY 2023: 3.4×FY 2024: 1.2×FY 2025: 2.5×
FY 2016 5y median 3.4× FY 2025
Quick Ratio 1.5×
FY 2016: 2.2×FY 2017: 1.5×FY 2018: 1.9×FY 2019: 1.6×FY 2020: 2.3×FY 2021: 2.5×FY 2022: 2.6×FY 2023: 2.2×FY 2024: 0.7×FY 2025: 1.5×
FY 2016 5y median 2.2× FY 2025
Debt / Equity 1.9×
FY 2016: 0.8×FY 2017: 1.9×FY 2018: 1.0×FY 2019: 1.0×FY 2020: 1.1×FY 2021: 1.0×FY 2022: 0.9×FY 2023: 1.1×FY 2024: 1.3×FY 2025: 1.9×
FY 2016 5y median 1.1× FY 2025
Net Debt / EBITDA -5.5×
FY 2016: 2.4×FY 2017: 12.3×FY 2018: 5.1×FY 2019: 5.6×FY 2020: 4.5×FY 2021: 3.2×FY 2022: 3.1×FY 2023: 5.5×FY 2024: 9.0×FY 2025: -5.5×
FY 2016 5y median 3.2× FY 2025
Interest Coverage 0.8×
FY 2016: 4.5×FY 2017: 1.3×FY 2018: 1.7×FY 2019: 1.7×FY 2020: 2.1×FY 2021: 3.9×FY 2022: 4.8×FY 2023: 2.2×FY 2024: 0.4×FY 2025: 0.8×
FY 2016 5y median 2.2× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31